Loma Linda University Health
Loma Linda, California, 92350, United States
Location status: Recruiting
NCT Number: NCT05551104
The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.
Interested in participating?
Request Info18 year and older
Female
Interventional
Phase 3
Loma Linda, California, 92350, United States
Location status: Recruiting
High blood pressure (hypertension) is one of the most common medical disorders in pregnancy and affects 10% of all pregnancies in the United States, with possible short-term and long-term health complications including increased risk of stroke, and liver, kidney, and heart disease. Management of severe high blood pressure after delivery involves medications to lower blood pressure, strict discharge instructions and close follow- up after delivery. Both oral Nifedipine and oral Labetalol are considered safe agents for the treatment of postpartum high blood pressure, however few studies exist that directly compare the two. The investigators want to conduct this study because they want to compare the effects of oral Nifedipine or oral Labetalol on postpartum hypertension. In this study, subjects will get either oral Nifedipine or oral Labetalol. Subjects will not get both. No experimental drugs or devices will be used.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of oral nifedipine to control postpartum hypertension.
Other names: Procardia, Procardia XL
Administration of oral labetalol to control postpartum hypertension.
Other names: Trandate
Time frame: 0-6 weeks following delivery
Requiring antihypertensive medication in the postpartum period, readmission for high blood pressure
Time frame: Number of hours between time of admission to time of discharge, up to 4 weeks from time of admission.
The length of hospital stay for mothers will be measured in hours from the time of admission to labor and delivery unit to the time of discharge from the post-partum unit.
Time frame: 0-6 weeks following delivery
The need to use a second (alternative) antihypertensive medication.
Contact information is provided by the study sponsor or research team.
Loma Linda University
Other
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension: A Randomized Control Trial (SCARPH)
Acronym: SCARPH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06576544
Cardiovascular Diseases, Cardiovascular Morbidity
La Jolla, California, United States
View Trial DetailsNCT06218355
Breast Diseases, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT06842875
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Newport, Rhode Island, United States
View Trial DetailsNCT06273436
Disease Attributes, Emergencies
Charleston, South Carolina, United States
View Trial Details